Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Unknown 7Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Leiomyoma 2Menorrhagia 1

Interventions

Saline Solution 6Fentanyl 6Sodium Chloride 5Letrozole 5Dexamethasone 5Pregabalin 4Ketamine 4Goserelin 4Gemcitabine 4Bevacizumab 4Tranexamic Acid 3Photochemotherapy 3Pemetrexed 3Paclitaxel 3Metformin 3Leuprolide 3Docetaxel 3Cyclophosphamide 3Carboplatin 3Capecitabine 3Acetaminophen 3ulipristal acetate 2sodium glycididazole 2nilotinib 2liposomal doxorubicin 2human papillomavirus vaccine, L1 type 16, 18 2flurbiprofen axetil 2fludarabine 2fluciclovine F-18 2epoetin beta 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Terminated × ulipristal acetate × Clear all
NCT04132349 2020-04-13

Ulipristal Acetate in Symptomatic Uterine Fibroid

Mỹ Đức Hospital

Phase 4 Terminated
25 enrolled

Leiomyoma, Menorrhagia

NCT02825719 2020-04-09

Ulipristal Use in Chinese Population

Queen Mary Hospital, Hong Kong

Phase 4 Terminated
31 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡